Cyclopharm Limited (ASX:CYC)
Australia · Delayed Price · Currency is AUD 0.5100
0.00 (0.00%)
Sep 2, 2026, 11:43 AM AEST
Cyclopharm Market Cap
Cyclopharm has a market cap or net worth of 64.12 million as of September 1, 2026. Its market cap has decreased by -41.12% in one year.
Market Cap
64.12M
Enterprise Value
59.68M
Revenue
34.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.51
ChartMarket Cap Chart
Since January 18, 2007, Cyclopharm's market cap has increased from 50.89M to 64.12M, an increase of 26.00%. That is a compound annual growth rate of 1.18%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2026 | 64.12M | -41.12% |
| Dec 30, 2025 | 108.91M | -38.17% |
| Dec 31, 2024 | 176.15M | -2.75% |
| Dec 29, 2023 | 181.14M | 66.37% |
| Dec 30, 2022 | 108.87M | -28.90% |
| Dec 30, 2021 | 153.13M | -23.69% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 158.95M |
| Saluda Medical | 117.19M |
| Lumos Diagnostics Holdings | 99.21M |
| Epiminder | 73.67M |
| SomnoMed | 73.39M |
| Compumedics | 50.94M |
| Cleo Diagnostics | 47.30M |
| HeraMED | 41.71M |